CD9: Differential expression of normal bone marrow cellular components and leukemic myeloid blasts
Aberrant CD9 expression can be useful differentiating normal from abnormal myeloid progenitors, with the highest level of expression in AML with PML::RARA in our cohort. There was differential expression between HSCs and CMPs in the small numbers studied. Normal mature B cells can be used as an internal negative control in most cases.
Authors
- Elizabeth Quirk
- Parastou Tizro (ORCID: https://orcid.org/0000-0003-1928-8967)
- Joo Y. Song (ORCID: https://orcid.org/0000-0003-3497-2513)
- Lori Soma (ORCID: https://orcid.org/0000-0003-0606-899X)
- Winston Lee (ORCID: https://orcid.org/0000-0002-1777-8519)
- Afreen Jasim (ORCID: https://orcid.org/0009-0000-0121-5175)
- Huiyan Ma (ORCID: https://orcid.org/0000-0002-3335-4775)
- Jessica R Hughes
- Scott Hwee
Institutions
- City Of Hope National Medical Center (US)
Publication Details
- Journal
- American Journal of Clinical Pathology
- Published
- 2025-07-25
- DOI
- https://doi.org/10.1093/ajcp/aqaf087
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00